Amanda Doherty-Kirby

Amanda Doherty-Kirby

Auto-generated profile, based on publicly available information

Amanda Doherty-Kirby

CanChild Centre for Childhood-Onset Disability Research, McMaster University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2026 in BMJ
Verified
Journal Article
Closed access
PDF file
ABAmi Baba
Ami Baba
MSMaureen Smith
Maureen Smith
BPBeth K Potter
Beth K Potter
ACAn-Wen Chan
An-Wen Chan
DMDavid Moher
David Moher
MOMartin Offringa
Martin Offringa
Appropriately designed, conducted, and reported randomised controlled trials (RCTs) in children and adolescents inform treatment and healthcare decisions made by young people, families, researchers, clinicians, regulators, funders, policymakers, and other interest holders. To critically evaluate, interpret, and apply trial results, readers require access to a complete and transparent report of what was planned, done, and found, taking unique considerations specific to children and adolescents into account. Harmonised guidance based on evidence and consensus is needed to optimise standardised reporting and reduce research waste in paediatric RCTs. As an extension to the Consolidated Standards of Reporting Trials (CONSORT) 2025 statement, the CONSORT-Children and Adolescents (CONSORT-C) 2026 reporting guideline aims to improve the quality and completeness of reporting of paediatric RCTs that involve participants aged 0-19 years. The Enhancing the Quality of Transparency of Health Research (EQUATOR) Network’s published framework primarily informed the development of CONSORT-C 2026. A literature review was conducted to generate a list of candidate reporting items. To obtain direct input from young people and family caregivers throughout the project, a Youth Advisory Group and a Family Caregiver Advisory Group were formed. An international Delphi study with a priori consensus thresholds, consensus meeting, group writing of the explanation and elaboration paper, and pilot testing were conducted. CONSORT-C 2026 consists of a checklist with 13 new reporting items, including one youth generated and six youth endorsed items; the accompanying explanation and elaboration paper explains all items and offers examples of good reporting. CONSORT-C 2026 can be considered a minimum set of reporting items applicable to paediatric RCT reports reflecting the priorities of clinicians, researchers, young people, family caregivers, and other interest holders. Widespread implementation and uptake of CONSORT-C 2026 should optimise the usability of trial results for these populations, improve the reproducibility of trial results, and reduce research waste.

1 May 2025 in Disability and Rehabilitation
Verified
Journal Article
Closed access
ASAlice Kelen Soper
Alice Kelen Soper
TLTrinity Lowthian
Trinity Lowthian
ADAmanda Doherty-Kirby
Amanda Doherty-Kirby
HMHolly Marini
Holly Marini
MSMelissa Shivnauth
Melissa Shivnauth
PRPeter and Suzanne Rosenbaum
Peter and Suzanne Rosenbaum
This scoping review explored the current worldwide landscape of school-based disability awareness programs that aim to increase students' positive attitudes towards their peers with disabilities. The scoping review followed Arksey and O'Malley's (2005) six-stage process, revised by Levac et al. (2010). A comprehensive search was completed in seven electronic databases from September 2011 to June 2023. Data management was supported by Covidence review software. Descriptive statistics summarised frequency counts on program development, delivery, and components. Thematic analysis was used to generate themes related to educational content. Seventy-two studies from 26 countries, published in six languages, were included in the review. Programs were delivered across various school settings (kindergarten, primary, and secondary schools) by teachers, individuals with disabilities, researchers, and other professionals. Secondary school activities emphasised social contact and simulations, while kindergarten and early elementary programs used vicarious contact methods through storybooks and videos depicting characters with disabilities. Educational content included general knowledge of disability, feelings towards people with disabilities, and skills to interact with disabled peers. There is a wide range of school-based disability awareness programs that can inform strategies and approaches to support inclusion of students with disabilities.

24 February 2026 in BMJ
Verified
Journal Article
Closed access
PDF file
ABAmi Baba
Ami Baba
MSMaureen Smith
Maureen Smith
BPBeth K Potter
Beth K Potter
ACAn-Wen Chan
An-Wen Chan
DMDavid Moher
David Moher
MOMartin Offringa
Martin Offringa
Randomised controlled trial (RCT) protocols contain essential details needed to understand and evaluate the trial’s planned aims, design, data collection methods, monitoring, data analysis, and participants’ safety. However, key information is often omitted from paediatric RCT protocols, including details on dose adjustments of interventions based on age, body surface area, or weight, developmental appropriateness of trial outcome measures and processes, or strategies to minimise participants’ anxiety and pain. These deficiencies impair the planning and implementation of potentially impactful trials for children and adolescents. Appropriate guidance is needed to support harmonised, comprehensive reporting of paediatric RCT protocols involving participants aged 0-19 years. The methodological framework for developing reporting guidelines published by the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network was implemented to develop a paediatric extension to the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2025 guidelines called SPIRIT-Children and Adolescents (SPIRIT-C) 2026. A list of candidate reporting items was generated from the literature, and a Youth Advisory Group and a Family Caregiver Advisory Group contributed vital input throughout the project. An international Delphi study with a priori consensus thresholds, a consensus meeting, group writing of the explanation and elaboration paper, and pilot testing of the draft guideline were conducted. SPIRIT-C 2026 consists of a checklist with 17 new reporting items for reporting paediatric RCT protocols; four items are youth generated and six youth endorsed. These can be considered a minimum set of reporting items pertinent to paediatric RCT protocols that are relevant to various interest holders, including young people, family caregivers, researchers, paediatric trialists, ethics committees, regulators, funders, and journal editors. The accompanying explanation and elaboration paper explains all items and offers examples of good reporting. Widespread implementation and uptake of SPIRIT-C 2026 should enhance the quality and usefulness of protocols for RCTs that involve participants from birth through adolescence and ultimately foster high quality paediatric trials.

25 February 2025 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
WZWasifa Zarin
Wasifa Zarin
SSSharmila Sreetharan
Sharmila Sreetharan
ADAmanda Doherty-Kirby
Amanda Doherty-Kirby
MSMichael Scott
Michael Scott
EZElaine Zibrowski
Elaine Zibrowski
ATAndrea C. Tricco
Andrea C. Tricco
To describe the Strategy for Patient-Oriented Research Evidence Alliance's methodological approach to systematically identify 23 high priority health research topics (three in 2021 and 20 in 2023) from patient partners (including caregivers) and members of the public across Canada and beyond. In 2021 and 2023, we collaborated with patient and public partners to co-design and co-conduct two priority setting initiatives. These initiatives involved a diverse group of patients, the public, clinicians, researchers, and health system decision-makers to systematically and collectively prioritize research topics based on their perceived importance and anticipated impact. We used a modified James Lind Alliance approach, where all participants were engaged as equal partners. The prioritization process consisted of the following steps: 1) identification and collection of research priorities from patients and the public; 2) summarizing the research priorities gathered; 3) conducting semistructured interviews (1-on-1 or focus groups depending on the number of submissions for each unique topic), conducting literature searches on each topic to identify relevant knowledge synthesis and appraising the quality of relevant evidence using the AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) checklist, and preparing lay summaries (1-2 pages) for each unique topic using a predefined template cocreated with patient partners; 4) conducting a priority setting exercise with a multidisciplinary panel consisting of an interim priority setting rating questionnaire to score each topic based on nine questions, followed by a virtual workshop to reach consensus on the final rating and ranking of topics; and 5) facilitating research by funding selected topics and providing capacity-building support to research teams. We conducted a formal process evaluation of engagement, transparency, information management, and considerations of values and context in 2023. A total of 98 topics were received across two research priority setting initiatives. Approximately, half the submissions were made by individuals who identified as patients (2021: 45% [n = 5] and 2023: 52% [n = 45]), whereas the rest identified as caregivers or members of the public. Topics were spread across 26 health themes, with arthritis and osteoporosis (27% [n = 3]) being the most common theme in 2021 and quality of care (26% [n = 23]) in 2023. Twenty-three priorities from 98 topics submitted by patients and public were selected. A formal process evaluation in 2023 revealed 85% of the respondents who participated in the priority setting panel "strongly agreed" that their experience was valuable and they would participate again in a future initiative. The 23 prioritized projects are currently being co-led with the patient and public partner topic submitters and nominated research teams. Priority setting exercises successfully engaged a diverse group of interested parties, resulting in the identification of relevant and impactful research topics. The positive feedback from participants suggests that these exercises were well-received and that similar methodologies should be applied and refined in future efforts. The Strategy for Patient-Oriented Research Evidence Alliance used a patient- and public-driven approach to set research priorities across different topics. They conducted two priority setting initiatives in 2021 and 2023, involving patients, the public, researchers, clinicians, and health system managers. This approach aimed to prioritize research topics based on their perceived importance and anticipated impact. A total of 98 topics were received across two research priority setting initiatives, with nearly half the submissions from patients and the other half from caregivers or members of the public. The topics covered 26 health themes, with arthritis and osteoporosis (2021) and quality of care (2023) being the most common themes. From these topics, the 23 highest priority topics were selected by a multidisciplinary priority setting panel. A formal process evaluation in 2023 revealed that 85% of the respondents who participated in the priority setting panel "strongly agreed" that their experience was valuable, and they would participate again in a future initiative. In conclusion, the priority setting exercises successfully engaged a diverse group of individuals and identified important research topics. The positive feedback suggests that this approach was well received and should be applied in future efforts.

30 September 2025 in Journal of Participatory Medicine
Verified
Journal Article
Open access
SKSasha Melanda Kullman
Sasha Melanda Kullman
LBLouise Bird
Louise Bird
ACAmy Clark
Amy Clark
ADAmanda Doherty-Kirby
Amanda Doherty-Kirby
DEDiana Ermel
Diana Ermel
ACAnna Maria Chudyk
Anna Maria Chudyk
Background: Patient engagement in research is the meaningful and active involvement of patient and caregiver partners (ie, patients and their family or friends) in research priority-setting, conduct, and governance. With the proper support, patient and caregiver partners can inform every stage of the research cycle, but common barriers often prevent their full engagement. Objective: This participatory qualitative study aimed to answer the question: What are the facilitators and barriers to patient engagement experienced by patient and caregiver partners in a Canadian research context? Methods: Participants were N=13 patient and caregiver partners (median age 62 y, IQR 58-69 y; 11/13, 85% women; 13/13, 100% White) from 4 provinces who completed 60‐90-minute semistructured videoconferencing interviews. The interviews were transcribed verbatim. A researcher and a patient partner reviewed the transcripts and curated a dataset of 90 participant quotations representing facilitators and barriers to patient engagement. This dataset was co-analyzed using participatory theme elicitation alongside 7 patient and caregiver partners with diverse identities who were not among the participants we interviewed and, therefore, contributed novel perspectives. Results: We generated four themes depicting factors that facilitate meaningful patient engagement alongside barriers that arise when these factors are not in place: (1) Co-defining roles and expectations; (2) demonstrating the value and impact of engagement; (3) psychological safety; and (4) community outreach, training, and education. We then discuss how barriers to enacting these 4 factors can be mitigated and provide a practical checklist of considerations for both researchers and patient and caregiver partners for engaging together throughout the research cycle. Conclusions: Research teams conducting patient and caregiver engagement activities should draw from our findings to mitigate barriers and facilitate meaningful engagement experiences.

24 February 2026 in BMJ
Verified
Journal Article
Closed access
PDF file
ABAmi Baba
Ami Baba
MSMaureen Smith
Maureen Smith
BPBeth K Potter
Beth K Potter
ACAn-Wen Chan
An-Wen Chan
DMDavid Moher
David Moher
MOMartin Offringa
Martin Offringa
Paediatric randomised controlled trials (RCTs) are key to evaluating new and existing interventions that can improve health outcomes in newborns, infants, children, and adolescents (aged 0-19 years). Well reported RCT protocols facilitate the planning and implementation of trials that generate high quality, reproducible evidence, and strengthen the foundations of paediatric healthcare decisions and ultimately improve patient outcomes. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2025 statement contains a checklist of essential reporting items and an explanation and elaboration paper. However, SPIRIT 2025 does not consider important elements that are unique to paediatric RCT protocols. As a paediatric extension to SPIRIT, we developed the SPIRIT-Children and Adolescents (SPIRIT-C) 2026 checklist, which this explanation and elaboration paper accompanies. We adopted a group writing approach to prepare this explanation and elaboration paper, and involved key partners with lived experience relevant to paediatric clinical trials, including family caregivers, trialists, child health researchers, clinicians, journal editors, and methodologists. This explanation and elaboration paper presents examples, explanations, and key elements for the 17 new SPIRIT-C 2026 reporting items; paediatric considerations with good reporting examples for six SPIRIT 2025 items; and a glossary. This paper also promotes the reporting of methodological rigor, patient safety, promotes a patient oriented approach, and facilitates the generation of high quality, reproducible trial evidence that will strengthen paediatric practice and policy decisions and ultimately improve patient outcomes.